AbbVie's Blood Cancer Combo Therapy Fails in Late-Stage Study
AbbVie has said a late-stage study of its experimental combination therapy failed to meaningfully increase the survival rate of patients without the disease worsening.
Reuters Health Information
source https://www.medscape.com/s/viewarticle/996945?src=rss
Reuters Health Information
source https://www.medscape.com/s/viewarticle/996945?src=rss
Comments
Post a Comment